SSTNIV, a syndecan-1-targeting peptide chimera, reverses immune suppression and inhibits myeloma progression. - Jung O; Beauvais DM; Ibaan GL; Wooldrik CC; Flietner E; Choi S; Zhang J; Rapraeger AC (Signal transduction and targeted therapy, 2026)